Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ergometrine maleate |
Is a |
False |
Ergometrine |
Inferred relationship |
Some |
|
Methylergometrine |
Is a |
False |
Ergometrine |
Inferred relationship |
Some |
|
Ergometrine adverse reaction |
Causative agent (attribute) |
True |
Ergometrine |
Inferred relationship |
Some |
1 |
Allergy to ergometrine |
Causative agent (attribute) |
False |
Ergometrine |
Inferred relationship |
Some |
|
Product containing ergometrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergometrine |
Inferred relationship |
Some |
1 |
Ergonovine provocation test |
Direct substance |
False |
Ergometrine |
Inferred relationship |
Some |
1 |
Allergy to oxytocin and ergometrine |
Causative agent (attribute) |
False |
Ergometrine |
Inferred relationship |
Some |
|
maléate d'ergométrine et oxytocine 500 microgrammes/5 unités/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergometrine |
Inferred relationship |
Some |
|
Product containing ergometrine and oxytocin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergometrine |
Inferred relationship |
Some |
2 |
Ergonovine provocation test |
Direct substance |
False |
Ergometrine |
Inferred relationship |
Some |
1 |
Allergy to ergometrine |
Causative agent (attribute) |
True |
Ergometrine |
Inferred relationship |
Some |
1 |
Allergy to oxytocin and ergometrine |
Causative agent (attribute) |
False |
Ergometrine |
Inferred relationship |
Some |
1 |
Allergy to oxytocin and ergometrine |
Causative agent (attribute) |
False |
Ergometrine |
Inferred relationship |
Some |
2 |
Ergonovine provocation test |
Direct substance |
True |
Ergometrine |
Inferred relationship |
Some |
2 |
Product containing ergometrine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergometrine |
Inferred relationship |
Some |
1 |
Ergometrine maleate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ergometrine |
Inferred relationship |
Some |
|
Ergometrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergometrine |
Inferred relationship |
Some |
1 |
Product containing ergometrine and oxytocin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergometrine |
Inferred relationship |
Some |
2 |
Ergometrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergometrine |
Inferred relationship |
Some |
1 |
Ergometrine and oxytocin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergometrine |
Inferred relationship |
Some |
2 |
Ergometrine and oxytocin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergometrine |
Inferred relationship |
Some |
2 |
Ergometrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergometrine |
Inferred relationship |
Some |
1 |
Product containing only ergometrine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergometrine |
Inferred relationship |
Some |
1 |
Ergometrine 200 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ergometrine |
Inferred relationship |
Some |
1 |
Ergometrine 200 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ergometrine |
Inferred relationship |
Some |
1 |
Administration of ergometrine and oxytocin |
Direct substance |
True |
Ergometrine |
Inferred relationship |
Some |
2 |